# Cellular Senescence and COVID-19 Long-Hauler Syndrome

> **NCT04903132** · — · ACTIVE_NOT_RECRUITING · sponsor: **Mayo Clinic** · enrollment: 200 (estimated)

## Conditions studied

- SARS-CoV2 Infection

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04903132
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-03-01
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04903132

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04903132, "Cellular Senescence and COVID-19 Long-Hauler Syndrome". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT04903132. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*